Gabapentinoid Use Tied to Higher Risk for Hip Fractures
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, Nov. 18, 2024 -- Gabapentinoid use is associated with an increased risk for hip fractures, according to a study published online Nov. 13 in JAMA Network Open.
Miriam T.Y. Leung, from the Centre for Medicine Use and Safety at Monash University in Melbourne, Australia, and colleagues investigated the association between gabapentinoids and the risk for hip fractures in older adults. The analysis included 28,293 patients hospitalized for hip fracture between March 1, 2013, and June 30, 2018.
The researchers found that 10.4 percent were dispensed a gabapentinoid before hip fracture. There was an increased risk for hip fracture with gabapentinoid dispensing (odds ratio, 1.96). The odds of hip fractures remained elevated when adjusting for the exposure-time trend and concomitant use of other central nervous system medications (odds ratio, 1.30). In patients with a Hospital Frailty Risk Score of ≥5 and chronic kidney disease, the associations between gabapentinoid dispensing and hip fracture were higher (odds ratios, 1.75 and 2.41, respectively).
"These findings suggest that in addition to the known risk associated with kidney impairment, gabapentinoids should be used with caution among patients at risk of hip fractures, especially those who are frail," the authors write.
Two authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-19 12:00
Read more
- Sexual Minority Women Report Better Sexual Functioning Than Heterosexual Women
- Ultraprocessed Foods Might Help Trigger Psoriasis
- Reported Use of Most Drugs Among Adolescents Remained Low in 2024
- Where One Lives Impacts Dementia Risk
- Trump Says He'll Try to Rid U.S. of Daylight Saving Time
- Newer Epilepsy Medications Used During Pregnancy Do Not Affect Neurological Development in Children
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions